There was an improvement in general symptoms of mood and depression (HADS)—as well as in insulin response—over the 8 weeks of intervention in both groups, with no significant difference between them; no differences were observed in BDNF levels; the IF group only showed a greater reduction in BF and alkaline phosphatase compared to the controls. The gene discussed is BDNF; the disease is major depressive disorder.